MedPath

Optimizing diagnosis of abdominal vein thrombosis with MRI- the Rhea study

Conditions
- non-symptomatic chronic (incidental) splanchnic vein thrombosis (SVT)- acute splanchnic vein thrombosis (SVT)- portal vein thrombosis (PVT)- mesenteric vein thrombosis (MVT)- splenic vein thrombosis (SpVT) - Budd-Chiairi syndrome (BCS)Nederlands:- asymptomatische chronische (incidentele) buivene trombose - acute buikvene trombose- poortader trombose - mesenteriale vene trombose - Milt vene trombose- Budd-Chiairi syndroom (BCS)
Registration Number
NL-OMON21809
Lead Sponsor
MC (Leids Universitair Medisch Centrum)
Brief Summary

none

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
73
Inclusion Criteria

Patients with confirmed acute SVT; definitions provided in paragraph 4.2 (Cases, group 1)

- Patients with confirmed non-symptomatic chronic SVT, defined by incident SVT treated for at least 3 months and with chronic thrombi on 2 serial imaging tests with at least 3 months interval (controls, group 2)

Exclusion Criteria

- MRI contra-indication (including but not limited to a cardiac pacemaker or subcutaneous defibrillator; vascular clips in the cerebral vessels; metal splinter in the eye, a hearing aid that cannot be removed; a neurostimulator that cannot be removed; a hydrocephalus pump)

- A medical condition, associated illness or co-morbid circumstances that precludes completion of the study procedures (MRI and 90-day follow-up assessment), including but not limited to life-expectancy less than 3 months, inability to lie flat, morbid obesity preventing use of MR and claustrophobia.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To explore the diagnostic accuracy of MRDTI in the diagnostic management of acute and chronic SVT in a prospective diagnostic proof of concept study
Secondary Outcome Measures
NameTimeMethod
1) To optimise MRDTI sequences for imaging SVT. <br /><br>2) To assess the interobserver agreement of the readers of MRDTI for suspected SVT. <br>
© Copyright 2025. All Rights Reserved by MedPath